Table 3.
A. LDL-C reduction (%) | ||||
Inverse Probability Weighted Regression Adjustment (IPWRA) | ||||
Group | Mean,% * | p value | 95% CI | |
lower | upper | |||
Monogenic | 45.9 | <0.001 | 42.0 | 49.8 |
Polygenic | 55.4 | 52.7 | 58.1 | |
Ancova | ||||
Group | Mean,% * | p value | 95% CI | |
lower | upper | |||
Monogenic | 41.5 | <0.001 | 35.4 | 47.6 |
Polygenic | 51.6 | 46.6 | 56.6 | |
Linear Regression Model | ||||
Variable | F(3,107) = 8.23 p < 0.001 | |||
Coefficient | p value | 95% CI | ||
lower | upper | |||
Constant | 27.41 | <0.001 | 15.61 | 39.20 |
Monogenic/Polygenic | −10.13 | <0.001 | −15.72 | −4.54 |
LDL baseline | 0.11 | <0.001 | 0.06 | 0.16 |
Diabetes melitus | −9.38 | 0.052 | −18.84 | 0.08 |
B. LDL-C Goal Achievement | ||||
Inverse Probability Weighted Regression Adjustment (IPWRA) | ||||
Group | Probability of goal achievement | p value | 95% CI | |
lower | upper | |||
Monogenic | 0.075 | 0.004 | 0.008 | 0.142 |
Polygenic | 0.245 | 0.151 | 0.339 | |
Risk Ratio Polygenic vs. Monogenic = 3.28 | 1.23 | 8.72 | ||
Logistic Regression | ||||
Variable | LR Chi2 (2) = 16.90 p < 0.001 | |||
Odds ratio | p value | 95% CI | ||
lower | upper | |||
Constant | 0.625 | 0.103 | 0.355 | 1.100 |
Monogenic/Polygenic | 0.281 | 0.023 | 0.094 | 0.840 |
CVD | 0.087 | 0.020 | 0.011 | 0.686 |